Hereditary Angioedema [clinicaltrials_resource:a5a8b7ada3fc3568d7fd05edcf37c0d9]
clinicaltrials:NCT00225147clinicaltrials:NCT00262301clinicaltrials:NCT00289211clinicaltrials:NCT00292981Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects [clinicaltrials:NCT00432510]clinicaltrials:NCT00438815clinicaltrials:NCT00456508clinicaltrials:NCT00457015clinicaltrials:NCT00462709clinicaltrials:NCT00500656clinicaltrials:NCT00748202clinicaltrials:NCT00851409clinicaltrials:NCT00912093clinicaltrials:NCT00914966clinicaltrials:NCT00997204clinicaltrials:NCT01005888clinicaltrials:NCT01059526clinicaltrials:NCT01095497clinicaltrials:NCT01095510C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation [clinicaltrials:NCT01151735]clinicaltrials:NCT01188564Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema [clinicaltrials:NCT01253382]Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients [clinicaltrials:NCT01359969]clinicaltrials:NCT01386658C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks [clinicaltrials:NCT01397864]clinicaltrials:NCT01426763Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema [clinicaltrials:NCT01457430]A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema [clinicaltrials:NCT01541423]A Call Center During HAE Attacks (SOS HAE) [clinicaltrials:NCT01679912]clinicaltrials:NCT01756157Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE [clinicaltrials:NCT01984788]Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema [clinicaltrials:NCT02052141]Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Subjects [clinicaltrials:NCT02093923]A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161 [clinicaltrials:NCT02125162]Study to Determine How BCX4161 is Metabolized and Eliminated by the Body [clinicaltrials:NCT02218294]clinicaltrials:NCT0224773912-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks [clinicaltrials:NCT02303626]First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Volunteers [clinicaltrials:NCT02448264]
condition [clinicaltrials_vocabulary:condition]
Hereditary Angioedema [clinicaltrials_resource:a5a8b7ada3fc3568d7fd05edcf37c0d9]
Bio2RDF identifier
a5a8b7ada3fc3568d7fd05edcf37c0d9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a5a8b7ada3fc3568d7fd05edcf37c0d9
identifier
clinicaltrials_resource:a5a8b7ada3fc3568d7fd05edcf37c0d9
title
Hereditary Angioedema
@en
label
Hereditary Angioedema [clinicaltrials_resource:a5a8b7ada3fc3568d7fd05edcf37c0d9]
@en